Inicio ›

Publications

Filtros: Autor es Sole, X.  [Restablecer todos los filtros]
2007
Pujana MA, Ruiz A, Badenas C, Puig-Butille JA, Nadal M, Stark M, et al. Molecular characterization of a t(9;12)(p21;q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor. Genes, chromosomes & cancer. 2007;46(2):155-62. Abstract
Hernández P, Solé X, Valls J, Moreno V, Capellá G, Urruticoechea A, et al. Integrative analysis of a cancer somatic mutome. Molecular cancer. 2007;6:13.
González JR, Armengol L, Solé X, Guinó E, Mercader JM, Estivill X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics (Oxford, England). 2007;23(5):644-5.
Vendrell E, Ribas M, Valls J, Solé X, Grau M, Moreno V, et al. Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients. International journal of oncology. 2007;30(5):1099-107.
Pujana MA, Han JD, Starita LM, Stevens KN, Tewari M, Ahn JS, et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nature genetics. 2007;39(11):1338-49.
2008
Valls J, Grau M, Solé X, Hernández P, Montaner D, Dopazo J, et al. CLEAR-test: combining inference for differential expression and variability in microarray data analysis. Journal of biomedical informatics. 2008;41(1):33-45.
Maxwell CA, Moreno V, Solé X, Gómez L, Hernández P, Urruticoechea A, et al. Genetic interactions: the missing links for a better understanding of cancer susceptibility, progression and treatment. Molecular cancer. 2008;7:4.
Solé X, Hernández P, de Heredia ML, Armengol L, Rodríguez-Santiago B, Gómez L, et al. Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility. BMC genomics. 2008;9:12.
Urruticoechea A, Aguilar H, Sole X, Capella G, Martin LA, Dowsett M, et al. Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer. Breast Cancer Res. Treat.. 2008;109:463-70.
2009
Solé X, Bonifaci N, López-Bigas N, Berenguer A, Hernández P, Reina O, et al. Biological convergence of cancer signatures. PloS one. 2009;4(2):e4544.
Fernández-Ramires R, Solé X, De Cecco L, Llort G, Cazorla A, Bonifaci N, et al. Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis. British journal of cancer. 2009;101(8):1469-80.
2010
De Keersmaecker K, Real PJ, Gatta GD, Palomero T, Sulis ML, Tosello V, et al. The TLX1 oncogene drives aneuploidy in T cell transformation. Nature medicine. 2010;16(11):1321-7. Abstract
Aguilar H, Solé X, Bonifaci N, Serra-Musach J, Islam A, López-Bigas N, et al. Biological reprogramming in acquired resistance to endocrine therapy of breast cancer. Oncogene. 2010;29(45):6071-83. Abstract
2011
Balart J, Pueyo G, de Llobet LI, Baro M, Sole X, Marin S, et al. The use of caspase inhibitors in pulsed-field gel electrophoresis may improve the estimation of radiation-induced DNA repair and apoptosis. Radiation oncology (London, England). 2011;6(1):6. Abstract
2012
Sanz-Pamplona R, Berenguer A, Cordero D, Riccadonna S, Solé X, Crous-Bou M, et al. Clinical Value of Prognosis Gene Expression Signatures in Colorectal Cancer: A Systematic Review. PloS one. 2012;7(11):e48877. Abstract
Della Gatta G, Palomero T, Perez-Garcia A, Ambesi-Impiombato A, Bansal M, Carpenter ZW, et al. Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL. Nature medicine. 2012;18(3):436-40. Abstract
Sanz-Pamplona R, Berenguer A, Sole X, Cordero D, Crous-Bou M, Serra-Musach J, et al. Tools for protein-protein interaction network analysis in cancer research. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2012;14(1):3-14. Abstract